TarginAct (5/2.5 mg, 10/5 mg, 20/10 mg, 40/20 mg)


Prolonged release tablets
scheduling status
S6
registration number
46/2.9/0645, 46/2.9/0646, 46/2.9/0647, 46/2.9/0648
What TarginAct (5/2.5 mg, 10/5 mg, 20/10 mg, 40/20 mg) contains
Oxycodone hydrochloride, naloxone hydrochloride.
other ingredients
Tablet core: Ethylcellulose, lactose monohydrate, magnesium stearate, stearyl alcohol, talc. TarginAct® 5 mg/2,5 mg contains hydroxypropylcellulose. TarginAct® 10 mg/5 mg; 20 mg/10 mg and 40 mg/20 mg contain povidone K30. Tablet coat: Polyvinylalcohol, macrogol, talc, titanium dioxide. TarginAct® 5 mg/2,5 mg contains Brilliant blue FCF aluminium lake. TarginAct® 10 mg/5 mg contains no additional colourant. TarginAct® 20 mg/10 mg contains Iron oxide red. TarginAct® 40 mg/20 mg contains Iron oxide yellow.
Therapeutic classification
N02AA55.
© 2026 SAHPRA. ALL RIGHTS RESERVED